PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-261

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 692 Posts.
    lightbulb Created with Sketch. 130
    Me too,@Werble. I accept that others have legitimate concerns, though. Many here seem to know a lot more about science and/or stock markets than I do, but I look at what other 'speculative' pre-revenue stocks on my watchlist have done and they have been erratic and unpredictable - even with tangible, proven assets such as in mining. I'm down around 50% on my PAR holding, have been down for years, but I'm still excited and optimistic.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.